Dr. Murali Mohan Angirekula, MD

Dr. Angirekula practices at Citrus Pain Clinic in Beverly Hills, Florida.

Dr. Angirekula's NPI, 1710942206, was assigned on April 19, 2006. Dr. Angirekula graduated from Kurnool Medical College in 1990. Dr. Angirekula holds Florida license ME72836.

Dr. Angirekula's primary practice is Citrus Pain Clinic, at 4065 N Lecanto Hwy, Beverly Hills, FL 34465-3555. The practice phone is (352) 527-2500.

Dr. Angirekula's primary practice is Citrus Pain Clinic in Beverly Hills, Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Angirekula practices. Vendor and product names are available with a free account.

Pain medicine is Dr. Angirekula's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Angirekula is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Angirekula's licenses on file in 4 states: Florida, Texas, Pennsylvania and Utah.

Dmand AI lists back pain injection, drug use disorders, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Angirekula treats.

CMS data shows 7,831 Medicare services from Dr. Angirekula across 13 procedure codes in 2024, for 758 Medicare patients. Medicare paid $294,408 for them. Every service was in an office.

CMS counts 758 Medicare patients who saw Dr. Angirekula in 2024. The largest group is 75 to 84, with 322 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Angirekula's median patient age at 74, with 57% women.

In 2024, Dr. Angirekula wrote 8,128 Medicare Part D claims for 1,090 patients. 100% of them were for generic drugs. CMS names the drug for 8,058 of them, across 28 drugs with 11 or more claims each, at $150,291 in total drug cost. In 2023, CMS named 7,902 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Angirekula for performance year 2024, reported as part of a group. Dr. Angirekula accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Angirekula. The most frequent topics are Angina, Unstable, Angina Pectoris and Cardiac Pacing, Artificial. Dr. Angirekula has published most often in Angiology. Dr. Angirekula's most frequent co-author is Manohar Angirekula, MD.

CMS Open Payments shows 2 general payments to Dr. Angirekula from 2 drug and device companies in 2017. Education make up the largest share, 54% of the total. Janssen Pharmaceuticals, Inc paid the most, $95.

Dr. Angirekula graduated from Kurnool Medical College in 1990.

Dr. Angirekula is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.